Molecule Details
| InChIKey | DLMBMHOJKBPKLK-UHFFFAOYSA-N |
|---|---|
| Compound Name | 3-(6-Ethoxynaphthalen-2-Yl)-1-(Piperidin-4-Ylmethyl)-1h-Pyrazolo[3,4-D]pyrimidin-4-Amine |
| Canonical SMILES | CCOc1ccc2cc(-c3nn(CC4CCNCC4)c4ncnc(N)c34)ccc2c1 |
| Clinical Status | Data-mined Candidate |
| Targets (Human+Pathogen) | 5 |
| Pfam Stratification | Cross-Family |
| Avg pChEMBL | 7.95 |
| Source | BindingDB;ChEMBL |
2D Structure
Activity Profile
Target Activities (5)
| Target | Gene | Organism | Category | Pfam | pChEMBL | Type | Source |
|---|---|---|---|---|---|---|---|
| P06239 | LCK | Homo sapiens | Human | PF07714 PF00017 PF00018 | 6.0 | IC50 | ChEMBL;BindingDB |
| A3FQ16 | Cryptosporidium parvum (strain Iowa II) | Pathogen | PF13499 PF00069 | 8.5 | IC50 | BindingDB | |
| Q6S4W0 | CDPK1 | Cryptosporidium parvum | Pathogen | PF13499 PF00069 | 8.5 | IC50 | BindingDB |
| Q8MMZ7 | PKG | Toxoplasma gondii | Pathogen | PF00027 PF00069 | 8.4 | IC50 | BindingDB |
| Q8IBS5 | CDPK4 | Plasmodium falciparum (isolate 3D7) | Pathogen | PF13499 PF00069 | 8.4 | IC50 | ChEMBL;BindingDB |